Karla works with eligible patients exploring wellness-focused peptide programs, including Tesamorelin, Ipamorelin, CJC-1295, GHK-Cu, GLOW Mix, KLOW, Wolverine Blend, NAD+ therapy, and physician-guided medical weight loss programs
There is no official link or licensed indication for using Ozempic (semaglutide) in the treatment of irritable bowel syndrome
doi: 10.1016/j.it.2020.11.002 55 De FloraS.BalanskyR.La MaestraS
The primary outcome was 30-day readmission, and secondary outcomes were documented dehiscence, infection, hematoma, and bleeding within 180 days after surgery
Lastly, maintain open communication with your healthcare team, discussing any concerns or changes in your health
Purity and concentration can vary wildly between manufacturers